Clinical Research Advantage

Clinical Research Advantage provides a range of research services to pharmaceutical, biotech and medical device companies, as well as contract research organizations. These services enable medical professionals to improve patient care while expediting the process of bringing pharmaceuticals, medical devices and vaccines to market. CRA accomplishes this by partnering with established physicians and trial sponsors to conduct phase II - IV clinical trials on a nationwide level. Members of our research staff are positioned in each clinic, which affords CRA rapid recruitment of reliable, qualified subjects into clinical trials. CRA is the country’s largest wholly owned network of clinical trial sites. Founded in 1992, CRA acquired Radiant Research in 2012 and Comprehensive Clinical Development in 2013. Combined, the companies have successfully completed more than 11,000 clinical trials. For more information, please visit www.crastudies.com.